TERT and head and neck squamous cell carcinoma: Antibodies to TERT in HNSCC patients have not been previously reported, arguing against their protective role by either antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis, or complement-dependent cytotoxicity.